Haemonetics Corporation stock extends bullish run above $72 as buyers dominate near resistance

Traders Union
All News
Business & Wealth
Companies
Haemonetics gains 1.43% today

Highlights

HAE maintains a strong bullish structure across short, medium, and long-term trends, trading well above major moving averages.
Momentum and breadth indicators are positive but readings signal the stock is overbought and approaching resistance near the top of its weekly range.
Expected trading range for the next week is $71.36 to $73.25, with 80% probability of sideways or upward consolidation unless a break below $71.36 occurs.

Haemonetics stated that the TEG 6s system provides clinicians valuable hemostasis insights while occupying minimal space. The system delivers high-quality results with a small footprint.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish structure as price holds above key averages and support

HAE is trading above the MA-20 ($62.12), MA-50 ($59.83), and MA-200 ($62.83), confirming a strong bullish structure for the short, medium, and long term. The Ichimoku Kijun (D1) at $61.44 acts as immediate support, with the price well above key trend levels.

Overbought signals as momentum remains strong and price rallies to range top

Momentum remains positive as the MACD (D1) signals a buy, and the ADX (D1) reads neutral, suggesting a moderate trend strength. Multiple oscillators—including RSI (D1) at 72.74, Stoch RSI (D1) at 100.00, and CCI (D1) at 113.12—flag overbought conditions, while a strongly positive BBP and AO (D1) reinforce prevailing buyer dominance. In today's session, HAE is trading $1.02 higher (up 1.43%) from the previous close, reflecting increased bullish activity. Over the past week, HAE has gained $1.02 (1.15%) from a previous close of $71.28, now sitting at the very top of its weekly range near resistance. Weekly volatility stands at 10.16%, and the price is exhibiting a steady recovery from earlier lows.

Consolidation likely as upside odds dominate amid pivotal boundaries

For the next week, the expected price range is $71.36 to $73.25, positioning the stock close to its annual midpoint between the 52-week low ($47.32) and high ($87.32). The probability of a price increase is high (80%), with a corresponding lower probability for a decline, based on W1 indicators (RSI, MACD, ADX, MA-50). The baseline scenario calls for consolidation between support at $62.83 (MA-200 D1) and resistance at $73.25, tracking sideways. A bullish scenario would see the price breaking through near-term resistance at $73.25 and extending toward the next key resistance. A bearish scenario could develop if HAE falls below $71.36, targeting support at $62.83 and $61.44.

Earlier, analysts noted that Haemonetics was exhibiting a broadly constructive technical setup but faced limited upside potential due to mixed momentum signals. With the latest developments, investors should monitor whether current price action confirms sustained support above key technical levels, as a shift below recent support could signal increased downside risk.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.